The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.
Could 30-minute full-body magnetic resonance imaging (MRI) exams be a reality in the near future?
The Food and Drug Administration (FDA) has granted 510(k) clearance for Ezra Flash (Ezra), an artificial intelligence-enabled software that enhances the quality of images derived from a fast MRI protocol, according to Ezra, the developer of the software.
Emphasizing that Ezra Flash was trained on hundreds of thousands of MRI scans from a proprietary dataset, Ezra said the technology facilitates simultaneous image quality and scan time reduction to the point where it can reduce the costs of full-body MRI by 30 percent.
Noting that Ezra Flash has received FDA clearance for brain imaging, the company plans to utilize the technology to launch the first 30-minute full-body MRI.
Possibly facilitating proactive cancer detection for a broader patient base beyond those with established risk factors, the FDA clearance of Ezra Flash may represent the “ … beginning of a sea change in how medical imaging is used,” noted Daniel K. Sodickson, M.D., Ph.D., the chief of innovation and director of the Center for Advanced Imaging Innovation and research in the Department of Radiology at New York University (NYU).
“Ezra Flash will increase the accessibility of early-warning MRI, and Ezra’s dataset of repeated scans over time will help it to prevent false positives and ensure that the warnings it provides are appropriate and accurate,” emphasized Dr. Sodickson.
(Editor’s note: For related content, see “Can Alternative MRI Techniques Help Enhance CyberKnife Treatment Imaging?”)
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.